相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。Dissecting the copper bioinorganic chemistry of the functional and pathological roles of the prion protein: Relevance in Alzheimer's disease and cancer
Yanahi Posadas et al.
CURRENT OPINION IN CHEMICAL BIOLOGY (2022)
Aducanumab: The first targeted Alzheimer's therapy
Pan Yang et al.
DRUG DISCOVERIES AND THERAPEUTICS (2021)
Increased isoform-specific phosphodiesterase 4D expression is associated with pathology and cognitive impairment in Alzheimer's disease
Dean Paes et al.
NEUROBIOLOGY OF AGING (2021)
Role of phosphodiesterases in the pathophysiology of neurodevelopmental disorders
Sebastien Delhaye et al.
MOLECULAR PSYCHIATRY (2021)
Calcium Dyshomeostasis in Alzheimer's Disease Pathogenesis
Roberta Cascella et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2021)
Defective Autophagy and Mitophagy in Alzheimer's Disease: Mechanisms and Translational Implications
Jie Chen et al.
MOLECULAR NEUROBIOLOGY (2021)
Development of novel phosphodiesterase 5 inhibitors for the therapy of Alzheimer's disease
Elisa Zuccarello et al.
BIOCHEMICAL PHARMACOLOGY (2020)
Rolipram treatment during consolidation ameliorates long-term object location memory in aged male mice
Mathieu E. Wimmer et al.
NEUROBIOLOGY OF LEARNING AND MEMORY (2020)
Therapeutic Potential of Phosphodiesterase Inhibitors against Neurodegeneration: The Perspective of the Medicinal Chemist
Giovanni Ribaudo et al.
ACS CHEMICAL NEUROSCIENCE (2020)
Targeting Amyloidogenic Processing of APP in Alzheimer's Disease
Jing Zhao et al.
FRONTIERS IN MOLECULAR NEUROSCIENCE (2020)
The role of CREB and BDNF in neurobiology and treatment of Alzheimer's disease
Meysam Amidfar et al.
LIFE SCIENCES (2020)
Therapeutic Strategies to Target Calcium Dysregulation in Alzheimer's Disease
Maria Calvo-Rodriguez et al.
CELLS (2020)
Alterations of the Endoplasmic Reticulum (ER) Calcium Signaling Molecular Components in Alzheimer's Disease
Mounia Chami et al.
CELLS (2020)
Ca2+ Dyshomeostasis Disrupts Neuronal and Synaptic Function in Alzheimer's Disease
John McDaid et al.
CELLS (2020)
Phosphodiesterase Inhibitors for Alzheimer's Disease: A Systematic Review of Clinical Trials and Epidemiology with a Mechanistic Rationale
Owen Sanders et al.
JOURNAL OF ALZHEIMERS DISEASE REPORTS (2020)
Control of Neuronal Ryanodine Receptor-Mediated Calcium Signaling by Calsenilin
Michael A. Grillo et al.
MOLECULAR NEUROBIOLOGY (2019)
Calcium Sensors in Neuronal Function and Dysfunction
Robert D. Burgoyne et al.
COLD SPRING HARBOR PERSPECTIVES IN BIOLOGY (2019)
Pharmacological Potential of Cilostazol for Alzheimer's Disease
Kenjiro Ono et al.
FRONTIERS IN PHARMACOLOGY (2019)
Multi-target design strategies for the improved treatment of Alzheimer's disease
Pengfei Zhang et al.
EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY (2019)
Vinpocetine mitigates aluminum-induced cognitive impairment in socially isolated rats
Azza A. Ali et al.
PHYSIOLOGY & BEHAVIOR (2019)
IP3 receptor isoforms differently regulate ER-mitochondrial contacts and local calcium transfer
Adam Bartok et al.
NATURE COMMUNICATIONS (2019)
Decreased Serum Brain-Derived Neurotrophic Factor (BDNF) Levels in Patients with Alzheimer's Disease (AD): A Systematic Review and Meta-Analysis
Ted Kheng Siang Ng et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2019)
Phosphodiesterase inhibitors say NO to Alzheimer's disease
Seyed Mohammad Nabavi et al.
FOOD AND CHEMICAL TOXICOLOGY (2019)
Xestospongin C, a Reversible IP3 Receptor Antagonist, Alleviates the Cognitive and Pathological Impairments in APP/PS1 Mice of Alzheimer's Disease
Zhao-Jun Wang et al.
JOURNAL OF ALZHEIMERS DISEASE (2019)
Calcium signalling: A common target in neurological disorders and neurogenesis
Talita Glaser et al.
SEMINARS IN CELL & DEVELOPMENTAL BIOLOGY (2019)
Neuronal Ryanodine Receptors in Development and Aging
Nawaf Abu-Omar et al.
MOLECULAR NEUROBIOLOGY (2018)
APOE genotype and cognition in healthy individuals at risk of Alzheimer's disease: A review
M. Clare O'Donoghue et al.
CORTEX (2018)
Betulinic acid, a natural PDE inhibitor restores hippocampal cAMP/cGMP and BDNF, improve cerebral blood flow and recover memory deficits in permanent BCCAO induced vascular dementia in rats
Madhu Kaundal et al.
EUROPEAN JOURNAL OF PHARMACOLOGY (2018)
Inositol 1,4,5-trisphosphate receptors and neurodegenerative disorders
Polina A. Egorova et al.
FEBS JOURNAL (2018)
Novel Phosphodiesterase Inhibitors for Cognitive Improvement in Alzheimer's Disease
Yinuo Wu et al.
JOURNAL OF MEDICINAL CHEMISTRY (2018)
Tau-targeting therapies for Alzheimer disease
Erin E. Congdon et al.
NATURE REVIEWS NEUROLOGY (2018)
Phosphodiesterase inhibition and modulation of corticostriatal and hippocampal circuits: Clinical overview and translational considerations
P. R. A. Heckman et al.
NEUROSCIENCE AND BIOBEHAVIORAL REVIEWS (2018)
Calcium signaling in Alzheimer's disease & therapies
Benjamin Chun-Kit Tong et al.
BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR CELL RESEARCH (2018)
Vinpocetine halts ketamine-induced schizophrenia-like deficits in rats: impact on BDNF and GSK-3β/β-catenin pathway
Hebatalla I. Ahmed et al.
NAUNYN-SCHMIEDEBERGS ARCHIVES OF PHARMACOLOGY (2018)
Cilostazol disrupts TLR-4, Akt/GSK-3β/CREB, and IL-6/JAK-2/STAT-3/SOCS-3 crosstalk in a rat model of Huntington's disease
Hanan El-Abhar et al.
PLOS ONE (2018)
cAMP Response Element-Binding Protein (CREB): A Possible Signaling Molecule Link in the Pathophysiology of Schizophrenia
Haitao Wang et al.
FRONTIERS IN MOLECULAR NEUROSCIENCE (2018)
Phosphodiesterase7 Inhibition Activates Adult Neurogenesis in Hippocampus and Subventricular Zone In Vitro and In Vivo
Jose A. Morales-Garcia et al.
STEM CELLS (2017)
Investigational phosphodiesterase inhibitors in phase I and phase II clinical trials for Alzheimer's disease
Jos Prickaerts et al.
EXPERT OPINION ON INVESTIGATIONAL DRUGS (2017)
IP3 receptor mutations and brain diseases in human and rodents
Chihiro Hisatsune et al.
JOURNAL OF NEUROCHEMISTRY (2017)
Identification and description of three families with familial Alzheimer disease that segregate variants in the SORL1 gene
Hakan Thonberg et al.
ACTA NEUROPATHOLOGICA COMMUNICATIONS (2017)
Post-translational remodeling of ryanodine receptor induces calcium leak leading to Alzheimer's disease-like pathologies and cognitive deficits
Alain Lacampagne et al.
ACTA NEUROPATHOLOGICA (2017)
Phosphodiesterase 5 inhibition as a therapeutic target for ischemic stroke: A systematic review of preclinical studies
Joakim N. E. Olmestig et al.
CELLULAR SIGNALLING (2017)
Inhibitor of Phosphodiestearse-4 improves memory deficits, oxidative stress, neuroinflammation and neuropathological alterations in mouse models of dementia of Alzheimer's Type
Amit Kumar et al.
BIOMEDICINE & PHARMACOTHERAPY (2017)
Cyclic GMP-mediated memory enhancement in the object recognition test by inhibitors of phosphodiesterase-2 in mice
Lindsay M. Lueptow et al.
PSYCHOPHARMACOLOGY (2016)
Protective effects of BAY 73-6691, a selective inhibitor of phosphodiesterase 9, on amyloid-β peptides-induced oxidative stress in in-vivo and in-vitro models of Alzheimer's disease
Jian Li et al.
BRAIN RESEARCH (2016)
The gain-of-function enhancement of IP3-receptor channel gating by familial Alzheimer's disease-linked presenilin mutants increases the open probability of mitochondrial permeability transition pore
Patrick Toglia et al.
CELL CALCIUM (2016)
Disrupted White Matter Network and Cognitive Decline in Type 2 Diabetes Patients
Junying Zhang et al.
JOURNAL OF ALZHEIMERS DISEASE (2016)
Oligomers of Amyloid Prevent Physiological Activation of the Cellular Prion Protein-Metabotropic Glutamate Receptor 5 Complex by Glutamate in Alzheimer Disease
Laura T. Haas et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2016)
Cyclic Nucleotide Control of Microtubule Dynamics for Axon Guidance
Hiroki Akiyama et al.
JOURNAL OF NEUROSCIENCE (2016)
Phosphodiesterase 11A (PDE11A), Enriched in Ventral Hippocampus Neurons, is Required for Consolidation of Social but not Nonsocial Memories in Mice
Shweta Hegde et al.
NEUROPSYCHOPHARMACOLOGY (2016)
Phosphodiesterase 10A inhibition attenuates sleep deprivation-induced deficits in long-term fear memory
Lengqiu Guo et al.
NEUROSCIENCE LETTERS (2016)
THE INOSITOL TRISPHOSPHATE/CALCIUM SIGNALING PATHWAY IN HEALTH AND DISEASE
Michael J. Berridge
PHYSIOLOGICAL REVIEWS (2016)
Preclinical profile of ITI-214, an inhibitor of phosphodiesterase 1, for enhancement of memory performance in rats
Gretchen L. Snyder et al.
PSYCHOPHARMACOLOGY (2016)
Cilostazol Modulates Autophagic Degradation of β-Amyloid Peptide via SIRT1-Coupled LKB1/AMPKα Signaling in Neuronal Cells
So Youn Park et al.
PLOS ONE (2016)
The Phosphodiesterase 10A Selective Inhibitor TAK-063 Improves Cognitive Functions Associated with Schizophrenia in Rodent Modelss
Eri Shiraishi et al.
JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS (2016)
Ca2+ homeostasis and endoplasmic reticulum (ER) stress: An integrated view of calcium signaling
Joachim Krebs et al.
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2015)
Phosphodiesterase-5 Inhibitors: Action on the Signaling Pathways of Neuroinflammation, Neurodegeneration, and Cognition
Christina Alves Peixoto et al.
MEDIATORS OF INFLAMMATION (2015)
Decreased levels of guanosine 3, 5-monophosphate (cGMP) in cerebrospinal fluid (CSF) are associated with cognitive decline and amyloid pathology in Alzheimer's disease
A. Ugarte et al.
NEUROPATHOLOGY AND APPLIED NEUROBIOLOGY (2015)
Calcium and ROS: A mutual interplay
Agnes Goerlach et al.
REDOX BIOLOGY (2015)
Advances in the therapy of Alzheimer's disease: targeting amyloid beta and tau and perspectives for the future
Harald Hampel et al.
EXPERT REVIEW OF NEUROTHERAPEUTICS (2015)
Structure, mechanism, and regulation of soluble adenylyl cyclases - similarities and differences to transmembrane adenylyl cyclases
Clemens Steegborn
BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR BASIS OF DISEASE (2014)
Toward a high-resolution structure of IP3R channel
Irina I. Serysheva
CELL CALCIUM (2014)
Neuronal calcium signaling: function and dysfunction
Marisa Brini et al.
CELLULAR AND MOLECULAR LIFE SCIENCES (2014)
The role of ryanodine receptor type 3 in a mouse model of Alzheimer disease
Jie Liu et al.
CHANNELS (2014)
Effects of daily low-dose treatment with phosphodiesterase type 5 inhibitor on cognition, depression, somatization and erectile function in patients with erectile dysfunction: a double-blind, placebo-controlled study
Y. S. Shim et al.
INTERNATIONAL JOURNAL OF IMPOTENCE RESEARCH (2014)
Calcium regulation of neural rhythms, memory and Alzheimer's disease
Michael J. Berridge
JOURNAL OF PHYSIOLOGY-LONDON (2014)
Ryanodine receptors: physiological function and deregulation in Alzheimer disease
Dolores Del Prete et al.
MOLECULAR NEURODEGENERATION (2014)
Phosphodiesterase from Daboia russelli russelli venom: Purification, partial characterization and inhibition of platelet aggregation
Jyotirmoy Mitra et al.
TOXICON (2014)
Inhibition of phoshodiesterase type 2 or type 10 reverses object memory deficits induced by scopolamine or MK-801
Olga A. H. Reneerkens et al.
BEHAVIOURAL BRAIN RESEARCH (2013)
Inhibition of endogenous phosphodiesterase 7 promotes oligodendrocyte precursor differentiation and survival
E. M. Medina-Rodriguez et al.
CELLULAR AND MOLECULAR LIFE SCIENCES (2013)
Presenilins regulate the cellular activity of ryanodine receptors differentially through isotype-specific N-terminal cysteines
Andrew J. Payne et al.
EXPERIMENTAL NEUROLOGY (2013)
PDE10 inhibition increases GluA1 and CREB phosphorylation and improves spatial and recognition memories in a Huntington's disease mouse model
Albert Giralt et al.
HIPPOCAMPUS (2013)
Cytotoxicity of Intracellular Aβ42 Amyloid Oligomers Involves Ca2+ Release from the Endoplasmic Reticulum by Stimulated Production of Inositol Trisphosphate
Angelo Demuro et al.
JOURNAL OF NEUROSCIENCE (2013)
Phosphodiesterase 7 inhibitor reduced cognitive impairment and pathological hallmarks in a mouse model of Alzheimer's disease
Rocio Perez-Gonzalez et al.
NEUROBIOLOGY OF AGING (2013)
Metabotropic Glutamate Receptor 5 Is a Coreceptor for Alzheimer Aβ Oligomer Bound to Cellular Prion Protein
Ji Won Um et al.
NEURON (2013)
Long-term depression and other synaptic plasticity in the cerebellum
Tomoo Hirano
PROCEEDINGS OF THE JAPAN ACADEMY SERIES B-PHYSICAL AND BIOLOGICAL SCIENCES (2013)
Presenilins regulate calcium homeostasis and presynaptic function via ryanodine receptors in hippocampal neurons
Bei Wu et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2013)
Cyclic AMP response element-binding protein (CREB) phosphorylation: A mechanistic marker in the development of memory enhancing Alzheimer's disease therapeutics
R. Scott Bitner
BIOCHEMICAL PHARMACOLOGY (2012)
Cyclic nucleotide phosphodiesterase (PDE) isozymes as targets of the intracellular signalling network: benefits of PDE inhibitors in various diseases and perspectives for future therapeutic developments
Therese Keravis et al.
BRITISH JOURNAL OF PHARMACOLOGY (2012)
Selective phosphodiesterase inhibitors improve performance on the ED/ID cognitive task in rats
Joshua S. Rodefer et al.
NEUROPHARMACOLOGY (2012)
Dantrolene ameliorates cognitive decline and neuropathology in Alzheimer triple transgenic mice
Jun Peng et al.
NEUROSCIENCE LETTERS (2012)
Amyloid Precursor Protein Processing and Alzheimer's Disease
Richard J. O'Brien et al.
ANNUAL REVIEW OF NEUROSCIENCE, VOL 34 (2011)
A Role for Calcineurin in Alzheimers Disease
Lindsay C. Reese et al.
Current Neuropharmacology (2011)
Demonstration of safety in Alzheimer's patients for intervention with an anti-hypertensive drug Nilvadipine: results from a 6-week open label study
S. P. Kennelly et al.
INTERNATIONAL JOURNAL OF GERIATRIC PSYCHIATRY (2011)
Disrupted energy metabolism and neuronal circuit dysfunction in cognitive impairment and Alzheimer's disease (vol 10, pg 187, 2011)
D. Kapogiannis et al.
LANCET NEUROLOGY (2011)
Downregulation of CREB expression in Alzheimer's brain and in Aβ-treated rat hippocampal neurons
Subbiah Pugazhenthi et al.
MOLECULAR NEURODEGENERATION (2011)
Disrupted energy metabolism and neuronal circuit dysfunction in cognitive impairment and Alzheimer's disease
Dimitrios Kapogiannis et al.
LANCET NEUROLOGY (2011)
Therapeutic utility of phosphodiesterase type I inhibitors in neurological conditions
Alexandre E. Medina
FRONTIERS IN NEUROSCIENCE (2011)
Cilostazol prevents amyloid β peptide25-35-induced memory impairment and oxidative stress in mice
Masayuki Hiramatsu et al.
BRITISH JOURNAL OF PHARMACOLOGY (2010)
Pre-Clinical Detection of Alzheimer's Disease Using FDG-PET, with or without Amyloid Imaging
Lisa Mosconi et al.
JOURNAL OF ALZHEIMERS DISEASE (2010)
Genetics of Alzheimer Disease
Lynn M. Bekris et al.
JOURNAL OF GERIATRIC PSYCHIATRY AND NEUROLOGY (2010)
CREB Binding Protein Is Required for Both Short-Term and Long-Term Memory Formation
Guiquan Chen et al.
JOURNAL OF NEUROSCIENCE (2010)
Phosphodiesterase 11A in brain is enriched in ventral hippocampus and deletion causes psychiatric disease-related phenotypes
Michele P. Kelly et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2010)
Inhibition of phosphodiesterase-4 reverses memory deficits produced by Aβ25-35 or Aβ1-40 peptide in rats
Yu-Fang Cheng et al.
PSYCHOPHARMACOLOGY (2010)
Local and Long-Range Reciprocal Regulation of cAMP and cGMP in Axon/Dendrite Formation
Maya Shelly et al.
SCIENCE (2010)
Presenilins Are Enriched in Endoplasmic Reticulum Membranes Associated with Mitochondria
Estela Area-Gomez et al.
AMERICAN JOURNAL OF PATHOLOGY (2009)
Endoplasmic reticulum Ca2+ release through ryanodine and IP3 receptors contributes to neuronal excitotoxicity
Asier Ruiz et al.
CELL CALCIUM (2009)
Amelioration of intracerebroventricular streptozotocin induced cognitive dysfunction and oxidative stress by vinpocetine - a PDE1 inhibitor
Rahul Deshmukh et al.
EUROPEAN JOURNAL OF PHARMACOLOGY (2009)
Phosphodiesterase 5 Inhibition Improves Synaptic Function, Memory, and Amyloid-β Load in an Alzheimer's Disease Mouse Model
Daniela Puzzo et al.
JOURNAL OF NEUROSCIENCE (2009)
Selective phosphodiesterase inhibitors: a promising target for cognition enhancement
Olga A. H. Reneerkens et al.
PSYCHOPHARMACOLOGY (2009)
Calcium signaling and neurodegenerative diseases
Ilya Bezprozvanny
TRENDS IN MOLECULAR MEDICINE (2009)
The effect of selective inhibition of cyclic GMP hydrolyzing phosphodiesterases 2 and 5 on learning and memory processes and nitric oxide synthase activity in brain during aging
K. Domek-Lopacinska et al.
BRAIN RESEARCH (2008)
The cytosolic N-terminus of presenilin-1 potentiates mouse ryanodine receptor single channel activity
Volodymyr Rybalchenko et al.
INTERNATIONAL JOURNAL OF BIOCHEMISTRY & CELL BIOLOGY (2008)
Amyloid Precursor Protein Trafficking, Processing, and Function
Gopal Thinakaran et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2008)
SERCA pump activity is physiologically regulated by presenilin and regulates amyloid β production
Kim N. Green et al.
JOURNAL OF CELL BIOLOGY (2008)
Increased intraneuronal resting [Ca2+] in adult Alzheimer's disease mice
Jose R. Lopez et al.
JOURNAL OF NEUROCHEMISTRY (2008)
Linking calcium to Aβ and Alzheimer's disease
Kim N. Green et al.
NEURON (2008)
The pathogenesis of alzheimers disease - Is it a lifelong Calciumopathy?
Grace E. Stutzmann
NEUROSCIENTIST (2007)
Nitric oxide in the central nervous system: neuroprotection versus neurotoxicity
Vittorio Calabrese et al.
NATURE REVIEWS NEUROSCIENCE (2007)
Calcium homeostasis and modulation of synaptic plasticity in the aged brain
Thomas C. Foster
AGING CELL (2007)
Molecular basis of the isoform-specific ligand-binding affinity of inositol 1,4,5-trisphosphate receptors
Miwako Iwai et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2007)
Inositol trisphosphate receptor Ca2+ release channels
J. Kevin Foskett et al.
PHYSIOLOGICAL REVIEWS (2007)
Role of voltage-gated L-type Ca2+ channel isoforms for brain function
J. Striessnig et al.
BIOCHEMICAL SOCIETY TRANSACTIONS (2006)
Cilostazol protects against brain white matter damage and cognitive impairment in a rat model of chronic cerebral hypoperfusion
Terubumi Watanabe et al.
STROKE (2006)
Delayed treatment with sildenafil enhances neurogenesis and improves functional recovery in aged rats after focal cerebral ischemia
Rui Lan Zhang et al.
JOURNAL OF NEUROSCIENCE RESEARCH (2006)
Neuroprotection by cilostazol, a phosphodiesterase type 3 inhibitor, against apoptotic white matter changes in rat after chronic cerebral hypoperfusion
JH Lee et al.
BRAIN RESEARCH (2006)
Signaling pathways regulating gene expression, neuroplasticity, and neurotrophic mechanisms in the action of antidepressants: A critical overview
D Tardito et al.
PHARMACOLOGICAL REVIEWS (2006)
Cyclic nucleotide phosphodiesterases: Molecular regulation to clinical use
Andrew T. Bender et al.
PHARMACOLOGICAL REVIEWS (2006)
Characterization of the first potent and selective PDE9 inhibitor using a cGMP reporter cell line
F Wunder et al.
MOLECULAR PHARMACOLOGY (2005)
Roflumilast -: an oral anti-inflammatory treatment for chronic obstructive pulmonary disease:: a randomised controlled trial
KF Rabe et al.
LANCET (2005)
Intraneuronal amyloid-β1-42 production triggered by sustained increase of cytosolic calcium concentration induces neuronal death
N Pierrot et al.
JOURNAL OF NEUROCHEMISTRY (2004)
Inhibition of phosphodiesterase 2 increases neuronal cGMP, synaptic plasticity and memory performance
FG Boess et al.
NEUROPHARMACOLOGY (2004)
BACE1 - The beta-secretase enzyme in Alzheimer's disease
R Vassar
JOURNAL OF MOLECULAR NEUROSCIENCE (2004)
Ca2+/CREB/CBP-dependent gene regulation:: a shared mechanism critical in long-term synaptic plasticity and neuronal survival
H Bito et al.
CELL CALCIUM (2003)
Alterations on phosphodiesterase type 7 and 8 isozyme mRNA expression in Alzheimer's disease brains examined by in situ hybridization
S Pérez-Torres et al.
EXPERIMENTAL NEUROLOGY (2003)
Calcium signalling: Dynamics, homeostasis and remodelling
MJ Berridge et al.
NATURE REVIEWS MOLECULAR CELL BIOLOGY (2003)
Amyloid β-peptide inhibition of the PKA/CREB pathway and long-term potentiation:: Reversibility by drugs that enhance cAMP signaling
OV Vitolo et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2002)
Spinal plasticity mediated by postsynaptic L-type Ca2+ channels
JF Perrier et al.
BRAIN RESEARCH REVIEWS (2002)
The molecular basis of CaMKII function in synaptic and behavioural memory
J Lisman et al.
NATURE REVIEWS NEUROSCIENCE (2002)
An important role of neural activity-dependent CaMKIV signaling in the consolidation of long-term memory
HJ Kang et al.
CELL (2001)
Cognitive effects of a Ginkgo biloba/vinpocetine compound in normal adults: systematic assessment of perception, attention and memory
J Polich et al.
HUMAN PSYCHOPHARMACOLOGY-CLINICAL AND EXPERIMENTAL (2001)
β-amyloid activates the mitogen-activated protein kinase cascade via hippocampal α7 nicotinic acetylcholine receptors:: In vitro and in vivo mechanisms related to Alzheimer's disease
KT Dineley et al.
JOURNAL OF NEUROSCIENCE (2001)
Apolipoprotein E4 stimulates cAMP response element-binding protein transcriptional activity through the extracellular signal-regulated kinase pathway
N Ohkubo et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2001)
Control of GluR1 AMPA receptor function by cAMP-dependent protein kinase
TG Banke et al.
JOURNAL OF NEUROSCIENCE (2000)